Indications for Use

Technology
Patients
Clinicians
About Us
Resources
Indications for Use

Get A Demo

Publications & Media > All Press Releases

Press Releases

2026

BrainScope Strengthens Executive Team with Veteran Commercial Leader David Wingate

BrainScope’s EEG-Based Biomarker Predicts Dementia Risk Up to 7 Years Before Initial Diagnosis, Published in Nature Scientific Reports

BrainScope Expands Advisory Board with Appointment of Six Renowned Neuroscience Leaders

2025

BrainScope Names Matt Adams as Chief Executive Officer

BrainScope Expands Board and Launches Advanced Deep Learning Platform to Enhance Brain Health Insights

2024

BrainScope Completes Proof-of-Concept for Groundbreaking Early Alzheimer’s Prediction Biomarker

Recent NFL Concussion and Parkinson’s News Brings Attention to the Long-Term Consequences of Head Impacts in Football

2023

BrainScope receives investment from the Alzheimer's Drug Discovery Foundation for Alzheimer's Prediction Biomarker

2022

BrainScope Named “Best New Diagnostic Technology Solution” in 2022 MedTech Breakthrough Awards Program

2021

JAMA Highlights Success of BrainScope's EEG-based Concussion Index As Reliable Indicator of Concussion

2019

Over 30% Reduction in Unnecessary Head CT Scans When Integrating FDA-Cleared BrainScope One

BrainScope Completes Large-Scale Clinical Studies of Concussion in Universities, High Schools and Concussion Clinics

BrainScope Announces Publication Describing Proprietary Concussion Biomarker to Assess Potential Severity and Predict Prolonged Recovery

BrainScope Receives FDA Clearance for Multi-Modal, Multi-Parameter Concussion Assessment

2018

Ron Klain Joins BrainScope Board of Directors

BrainScope Honors Veterans Day and Supports U.S. Army Deployment of Traumatic Brain Injury (TBI) and Concussion Assessment Devices

BrainScope Receives $4.5 Million Department of Defense Contract to Add Ocular Assessment to Future Concussion Products

BrainScope Receives Prix Galien Award Nomination for Its Concussion and Traumatic Brain Injury Assessment Product

Over 30% Potential Cost Reduction to Payers and Patients through Integration of BrainScope One for Mild Traumatic Brain Injury / Concussion Assessment

BrainScope Initiates Teenage and Young Adult Multi-Site Clinical Study for Concussion Assessment Product

Using BrainScope One in Urgent Care Centers Shows Potential 75% Reduction in Head Injury Referrals to Emergency Departments

BrainScope One Demonstrated the Potential to Reduce Head CT Scans By One-Third in Emergency Department Use

2017

BrainScope Initiates Development of Pediatric Product for Objective Assessment of Traumatic Brain Injury, Including Concussion

BrainScope Completes $16 Million Equity Fundraise

BrainScope Receives Frost & Sullivan Best Practices Award in Traumatic Brain Injury Assessment

Strong Utility of BrainScope’s Brain Function Index for Head Injury Assessment Demonstrated in Validation Trial

One-Third Potential Reduction in Unnecessary Head CT Scans Demonstrated in BrainScope One Study

Multi-Year Study Using BrainScope's Brain Function Index Suggests Compelling Utility as an Objective Biomarker for Concussion

BrainScope One Revolutionizes Brain Injury Assessment for Urgent Care Clinics

BrainScope Biomarker Adds Significant Prognostic Accuracy for Rapid Assessment of Traumatic Brain Injury

BrainScope Announces Publication Demonstrating Extremely High Accuracy of the Ahead 300 for Identification of Traumatic Brain Injury in a Large Prospective Validation Study

BrainScope Launches the Ahead 300 for Objective Assessment of Mild Head Injury, Including Concussion

2016

BrainScope Announces FDA Clearance of the First Handheld Medical Device for Assessment of the Full Spectrum of Traumatic Brain Injury

BrainScope Awarded Maryland Emerging Life Science Business of the Year

BrainScope’s Objective Concussion Assessment Technology Showcased at NFL Annual Meeting

2015

BrainScope to Present at the 27th Annual Piper Jaffray Healthcare Conference

GE and the NFL Award BrainScope with Further Funding

BrainScope's Ahead 200 Device Cleared by FDA for Adjunctive Assessment of Traumatic Brain Injury

BrainScope Announces Publication Demonstrating High Accuracy For Identification of Acute Stroke

2014

BrainScope Announces FDA Clearance of Ahead 100 Device for Adjunctive Assessment of Traumatic Brain Injury

BrainScope Collects $15.9M From Military for Traumatic Brain Injury Detection

BrainScope Awarded over $15.9 Million in Department of Defense Research Contracts

BrainScope Announces Publication of Independent, Prospective Validation Study Demonstrating High Accuracy For Identification of Traumatic Intracranial Hematomas

BrainScope Receives ISO 13485 Certification

BrainScope Receives GE NFL Head Health Challenge I Award

2012

BrainScope Awarded Montgomery County Emerging Business of the Year

BrainScope® Awarded $2.67 Million / U.S. Army Rapid Innovation Fund Research Contract

BrainScope Announces Publication of Findings From Three Years of Concussion Studies in Football Players

BrainScope Strengthens Executive Leadership Team

2011

Maryland Venture Fund Makes Initial Investment in BrainScope® to Help Develop Device to Assess Traumatic Brain Injury / Concussion

BrainScope Awarded $7.5 Million Department of Defense Research Contract for Assessment of Traumatic Brain Injury

BrainScope Announces Concurrence with FDA on Study Design for Its Traumatic Brain Injury Assessment Device

2010

BrainScope Announces Findings of Traumatic Brain Injury Study in the Emergency Department

BrainScope Announces Release of Concussion Findings in High School and College Football Players

2009

Gail Wilensky, Ph.D. Joins BrainScope Board of Directors

BrainScope Receives FDA Clearance for Portable EEG Device

The Honorable James Peake, M.D. Joins BrainScope's Board of Directors

BrainScope Positioned to Identify Traumatic Brain Injuries Suffered by Military Troops

2008

BrainScope Company, Inc. Announces New Investment and Leadership to Fuel Growth

Contact us
- info@brainscope.com
- 855.927.2461

©2026 BrainScope Company Inc | Terms of Use | Privacy Notice | Purchase Terms